Viva ben Femenine Supplement, Dietary Supplement 30 Softgels
Recalling firm: Duy Drugs Inc.
Why it was recalled
Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Apr 24, 2019.
Check your package
Compare the exact product and package details with the label you have.
ProductViva ben Femenine Supplement, Dietary Supplement 30 Softgels
FDA code information
Lot No. 0117221
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Viva ben Femenine Supplement, Dietary Supplement 30 Softgels
Original FDA recall reason
Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.
Recall details
- Recall number
- F-3355-2017
- Event ID
- 77715
- FDA status
- Terminated
- Initiated
- Jul 21, 2017
- Reported
- Aug 16, 2017
- Classified
- Aug 8, 2017
- Terminated
- Apr 24, 2019
- Quantity
- 1800 bottles
- Location
- Doral, FL, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
Where it was distributed
Domestic distribution only.
FDA source record · F-3355-2017
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.